The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR & NPF Highlight Medicare Access Challenges in Capitol Hill Briefing

ACR & NPF Highlight Medicare Access Challenges in Capitol Hill Briefing

July 5, 2018 • By Carina Stanton

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Concerns about how the Trump administration’s ideas to lower drug prices could reduce patient access to medicines led the ACR to speak out on many different fronts.

You Might Also Like
  • ACR Hosts Arthritis 101 Briefing on Capitol Hill
  • ACR Participates in Briefing to Highlight Importance of Biomedical Research
  • ACR Hill Visits Yield Key Bill Support; Plus Medicare, Biosimilar Wins
Also By This Author
  • 3 Ways to Advance the Med-Peds Role in Rheumatology

On June 25, at a briefing hosted by the ACR and the National Psoriasis Foundation (NPF), a packed room of Congressional staffers and reporters learned from rheumatologists and patients about the challenges involved when patients transition to Medicare. The briefing also addressed how the treatment of chronic conditions, such as arthritis, is being negatively impacted by current drug pricing that could worsen if proposed price changes are enacted, explains Angus Worthing, MD, FACR, FACP, chair of the ACR’s Government Affairs Committee.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Drug Pricing & Treatment Access
“The ways the U.S. drug pricing and drug distribution systems affect our patients are quite complex, and I think we were able to raise awareness on Capitol Hill about how to distinguish between the kinds of reforms that can improve our patients’ access to medicines and those that can worsen access,” Dr. Worthing says.

At the briefing, Dr. Worthing spoke about what a rheumatologist is and how important it is to protect access to breakthrough treatments that have revolutionized rheumatology care, and continue to prevent disability and early death for patients. “I answered questions about the Trump administration’s plans to move Part B drugs into the Part D system, and some of the barriers to the uptake of biosimilars as a way of lowering drug prices.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Colin Edgerton, MD, FACP, RhMSUS, chair of the ACR’s Committee on Rheumatologic Care (CORC), also spoke at the briefing, and hopes this latest discussion and other dialogue the ACR is leading will help legislators realize the difficulties patients have in accessing treatment. The hope is that these decision makers will incorporate this information into current discussions on medication pricing, such as preserving the Part B program as is, and not following the administration’s plans to transition all or part of the Part B benefit into a system that looks more like Part D.

“The Medicare Part D benefit uses utilization management, such as formularies, fail-first policies, step therapy, prior authorization and cost-tiering, [which] makes it difficult for patients to access biologic medicines for treatment of conditions, such as psoriatic arthritis and rheumatoid arthritis. In contrast, the Medicare Part B benefit does an excellent job of maintaining patient access to these therapies with minimal hassle,” Dr. Edgerton explains.

“It would be a shame for the administration to use these tools to reduce drug prices by reducing access to critical treatments,” Dr. Worthing adds.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: American College of Rheumatology, Conditions, Legislation & Advocacy Tagged With: ACR briefing, drug pricing, National Psoriasis Foundation (NPF), transition to Medicare

You Might Also Like:
  • ACR Hosts Arthritis 101 Briefing on Capitol Hill
  • ACR Participates in Briefing to Highlight Importance of Biomedical Research
  • ACR Hill Visits Yield Key Bill Support; Plus Medicare, Biosimilar Wins
  • ACR Board of Directors Advocates for Rheumatology on Capitol Hill

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.